Reduced p57Kip2 expression is associated with high tumor aggressiveness and poor prognosis in several types of tumors, such as gastric, colorectal, pancreatic, breast and lung carcinoma as well as leukemia (103, 104, 219–221). Here, CDKN1C is linked to neoplasm.